 Robert Rogers
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 15 | 2021 | 379 | 3.130 |
Why?
| | Endovascular Procedures | 7 | 2020 | 269 | 1.470 |
Why?
| | Angioplasty, Balloon | 4 | 2014 | 90 | 1.440 |
Why?
| | Lower Extremity | 7 | 2021 | 337 | 1.410 |
Why?
| | Stents | 7 | 2018 | 475 | 1.370 |
Why?
| | Tibial Arteries | 3 | 2017 | 13 | 1.310 |
Why?
| | Ischemia | 3 | 2020 | 363 | 1.120 |
Why?
| | Arterial Occlusive Diseases | 3 | 2011 | 73 | 1.050 |
Why?
| | Natriuretic Peptide, Brain | 4 | 2009 | 99 | 1.040 |
Why?
| | Blood Gas Monitoring, Transcutaneous | 1 | 2020 | 1 | 0.720 |
Why?
| | Ankle Brachial Index | 1 | 2020 | 30 | 0.710 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2020 | 32 | 0.710 |
Why?
| | Perfusion Imaging | 1 | 2020 | 44 | 0.700 |
Why?
| | Angiography | 2 | 2020 | 177 | 0.700 |
Why?
| | Foot | 1 | 2020 | 104 | 0.670 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2018 | 399 | 0.650 |
Why?
| | Early Termination of Clinical Trials | 1 | 2018 | 14 | 0.620 |
Why?
| | Sample Size | 1 | 2018 | 115 | 0.600 |
Why?
| | Patient Selection | 2 | 2018 | 654 | 0.570 |
Why?
| | Atherectomy | 2 | 2014 | 33 | 0.550 |
Why?
| | Cerebral Revascularization | 1 | 2015 | 15 | 0.520 |
Why?
| | Endarterectomy, Carotid | 1 | 2015 | 41 | 0.510 |
Why?
| | Aspirin | 1 | 2018 | 326 | 0.510 |
Why?
| | Carotid Artery Diseases | 1 | 2015 | 58 | 0.510 |
Why?
| | Vascular Surgical Procedures | 4 | 2021 | 262 | 0.500 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 38 | 0.450 |
Why?
| | Vascular System Injuries | 1 | 2014 | 64 | 0.430 |
Why?
| | Femoral Artery | 1 | 2014 | 167 | 0.420 |
Why?
| | Vascular Calcification | 1 | 2014 | 107 | 0.410 |
Why?
| | Treatment Outcome | 16 | 2021 | 9159 | 0.400 |
Why?
| | Stroke | 3 | 2018 | 1016 | 0.380 |
Why?
| | Iliac Artery | 1 | 2010 | 44 | 0.350 |
Why?
| | Intermittent Claudication | 3 | 2015 | 108 | 0.340 |
Why?
| | Radiographic Image Enhancement | 1 | 2009 | 58 | 0.330 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2008 | 103 | 0.300 |
Why?
| | Elasticity Imaging Techniques | 1 | 2008 | 44 | 0.300 |
Why?
| | Coronary Vessels | 1 | 2009 | 229 | 0.290 |
Why?
| | Carotid Stenosis | 2 | 2018 | 78 | 0.290 |
Why?
| | Coronary Angiography | 1 | 2009 | 307 | 0.280 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1805 | 0.280 |
Why?
| | Humans | 30 | 2022 | 115589 | 0.260 |
Why?
| | Constriction, Pathologic | 3 | 2011 | 210 | 0.260 |
Why?
| | Electrocardiography | 1 | 2008 | 560 | 0.250 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 691 | 0.250 |
Why?
| | Aged | 14 | 2021 | 19250 | 0.250 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 1724 | 0.240 |
Why?
| | Heart Ventricles | 1 | 2009 | 712 | 0.240 |
Why?
| | Middle Aged | 14 | 2021 | 26998 | 0.230 |
Why?
| | Coronary Artery Disease | 1 | 2009 | 607 | 0.220 |
Why?
| | Male | 19 | 2021 | 55949 | 0.210 |
Why?
| | Community Health Services | 2 | 2015 | 212 | 0.210 |
Why?
| | Risk Assessment | 5 | 2021 | 2987 | 0.210 |
Why?
| | Walking | 3 | 2015 | 425 | 0.200 |
Why?
| | Ulcer | 1 | 2021 | 28 | 0.200 |
Why?
| | Leg | 2 | 2021 | 227 | 0.190 |
Why?
| | Hematoma | 1 | 2021 | 50 | 0.190 |
Why?
| | Prosthesis Design | 2 | 2014 | 287 | 0.180 |
Why?
| | Syndrome | 1 | 2021 | 339 | 0.180 |
Why?
| | Exercise Therapy | 2 | 2015 | 351 | 0.180 |
Why?
| | Neck | 2 | 2017 | 84 | 0.180 |
Why?
| | Postoperative Complications | 3 | 2020 | 2161 | 0.170 |
Why?
| | Radiography, Interventional | 2 | 2011 | 111 | 0.170 |
Why?
| | Radiography | 2 | 2014 | 826 | 0.170 |
Why?
| | Reproducibility of Results | 3 | 2020 | 2800 | 0.170 |
Why?
| | Cardiology | 1 | 2022 | 260 | 0.170 |
Why?
| | Diabetes Complications | 1 | 2021 | 212 | 0.170 |
Why?
| | Vascular Diseases | 1 | 2022 | 230 | 0.170 |
Why?
| | Risk Factors | 6 | 2021 | 8697 | 0.170 |
Why?
| | Aorta | 1 | 2021 | 353 | 0.160 |
Why?
| | Specialization | 1 | 2020 | 117 | 0.160 |
Why?
| | Acute Disease | 1 | 2021 | 914 | 0.160 |
Why?
| | Reperfusion | 1 | 2018 | 38 | 0.160 |
Why?
| | Time Factors | 7 | 2020 | 6165 | 0.160 |
Why?
| | Regional Blood Flow | 1 | 2020 | 414 | 0.160 |
Why?
| | Female | 16 | 2021 | 59913 | 0.150 |
Why?
| | Upper Extremity | 1 | 2018 | 84 | 0.150 |
Why?
| | Counseling | 2 | 2017 | 347 | 0.140 |
Why?
| | Retrospective Studies | 9 | 2021 | 12608 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2017 | 41 | 0.140 |
Why?
| | Colorado | 6 | 2018 | 4113 | 0.140 |
Why?
| | Heart Failure | 1 | 2009 | 1963 | 0.140 |
Why?
| | Patient Readmission | 1 | 2021 | 609 | 0.130 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 117 | 0.130 |
Why?
| | Critical Illness | 1 | 2020 | 645 | 0.120 |
Why?
| | Exercise Test | 2 | 2015 | 539 | 0.120 |
Why?
| | Medicare | 1 | 2020 | 666 | 0.120 |
Why?
| | Life Style | 1 | 2017 | 429 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2016 | 124 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 646 | 0.120 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2014 | 33 | 0.120 |
Why?
| | Alloys | 1 | 2014 | 31 | 0.110 |
Why?
| | Double-Blind Method | 1 | 2018 | 1659 | 0.110 |
Why?
| | Rupture | 1 | 2014 | 95 | 0.110 |
Why?
| | Comorbidity | 3 | 2017 | 1473 | 0.110 |
Why?
| | Ultrasonography, Interventional | 1 | 2014 | 125 | 0.110 |
Why?
| | Internship and Residency | 1 | 2022 | 951 | 0.100 |
Why?
| | Survival Analysis | 1 | 2015 | 1219 | 0.100 |
Why?
| | California | 3 | 2018 | 367 | 0.100 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2014 | 180 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1180 | 0.100 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 684 | 0.100 |
Why?
| | Vascular Patency | 1 | 2011 | 97 | 0.090 |
Why?
| | Creatinine | 2 | 2009 | 430 | 0.090 |
Why?
| | United States | 4 | 2020 | 12295 | 0.090 |
Why?
| | Logistic Models | 2 | 2018 | 1856 | 0.090 |
Why?
| | Coronary Restenosis | 1 | 2009 | 18 | 0.080 |
Why?
| | Diastole | 1 | 2009 | 134 | 0.080 |
Why?
| | Aged, 80 and over | 3 | 2021 | 6417 | 0.080 |
Why?
| | Artifacts | 1 | 2009 | 122 | 0.080 |
Why?
| | Equipment Design | 1 | 2010 | 517 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2015 | 931 | 0.080 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 962 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1405 | 0.080 |
Why?
| | Movement | 1 | 2009 | 246 | 0.070 |
Why?
| | Incidence | 3 | 2021 | 2335 | 0.070 |
Why?
| | Prognosis | 2 | 2017 | 3339 | 0.070 |
Why?
| | Recurrence | 2 | 2020 | 952 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2578 | 0.070 |
Why?
| | Biomarkers | 3 | 2014 | 3467 | 0.070 |
Why?
| | Graft Rejection | 1 | 2009 | 533 | 0.060 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 325 | 0.060 |
Why?
| | Software | 1 | 2009 | 541 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1718 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 815 | 0.060 |
Why?
| | Heart Transplantation | 1 | 2009 | 671 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 2907 | 0.050 |
Why?
| | Body Mass Index | 1 | 2009 | 1971 | 0.050 |
Why?
| | Registries | 2 | 2021 | 1770 | 0.050 |
Why?
| | Hospitalization | 2 | 2020 | 1765 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 21 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 39 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 41 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 48 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 113 | 0.040 |
Why?
| | Retreatment | 1 | 2018 | 70 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2017 | 39 | 0.040 |
Why?
| | Obesity | 1 | 2009 | 2517 | 0.040 |
Why?
| | Aneurysm, False | 1 | 2017 | 46 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 478 | 0.030 |
Why?
| | Head | 1 | 2017 | 86 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 238 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 852 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 101 | 0.030 |
Why?
| | Clinical Competence | 1 | 2022 | 912 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1138 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 69 | 0.030 |
Why?
| | Quality of Life | 2 | 2015 | 2385 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2015 | 4440 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 621 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2015 | 223 | 0.030 |
Why?
| | Physical Endurance | 1 | 2014 | 223 | 0.030 |
Why?
| | Adult | 2 | 2017 | 30719 | 0.030 |
Why?
| | Heart | 1 | 2017 | 608 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 250 | 0.030 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2015 | 231 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2015 | 741 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1087 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2014 | 352 | 0.020 |
Why?
| | Recovery of Function | 1 | 2015 | 577 | 0.020 |
Why?
| | Patient Compliance | 1 | 2015 | 524 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 1650 | 0.020 |
Why?
| | Program Evaluation | 1 | 2015 | 836 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1377 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 941 | 0.020 |
Why?
| | Endocardium | 1 | 2009 | 30 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2829 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1093 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2009 | 299 | 0.020 |
Why?
| | Stroke Volume | 1 | 2009 | 509 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 467 | 0.020 |
Why?
| | Biopsy | 1 | 2009 | 1056 | 0.020 |
Why?
| | Hemodynamics | 1 | 2009 | 968 | 0.010 |
Why?
| | Myocardium | 1 | 2009 | 926 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 4665 | 0.010 |
Why?
|
|
Rogers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|